Angiogenesis assays: A critical overview

Clinical Chemistry

Volumn 49, Issue 1, 2003, Pages 32-40

  Auerbach, Robert ^a   Lewis, Rachel ^b   Shinners, Brenda ^b   Kubai, Louis ^b   Akhtar, Nasim ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MATRIGEL; REAGENT;

ANGIOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CHICKEN; CHORIOALLANTOIS; CORNEA NEOVASCULARIZATION; DIAGNOSTIC VALUE; EYE DISEASE; HUMAN; HUMAN CELL; INFLAMMATION; METASTASIS; PROCESS DEVELOPMENT; QUANTITATIVE DIAGNOSIS; REVIEW; TUMOR GROWTH; VASCULAR RING;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL MOVEMENT; CHICK EMBRYO; CORNEA; ENDOTHELIUM, VASCULAR; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN CULTURE TECHNIQUES;

EID: 0037233190     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.1.32     Document Type: Review

References (42)

1. Jain RK, Schlenger K, Hōckel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med 1997;3:1203-8.
2. Auerbach R, Popp BL, Kiley LM, Gilligan BJ. Angiogenesis assays: problems, pitfalls and potential. In: Hori W, ed. Therapeutic implications and mechanisms of angiogenesis - inhibitors and stimulators. IBC Biomedical Library Series, Westborough, MA: IBC USA Conferences, Inc., 1996:1.3.1-1.3.9.
3. Auerbach R, Auerbach W, Polakowski I. Assays for angiogenesis. Pharmacol Ther 1991;51:1-11.
4. Auerbach W, Auerbach R. Angiogenesis inhibition: a review. Pharmacol Ther 1994;63:265-311.
5. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001;86:23-33.
6. Auerbach R, Akhtar N, Lewis RL, Shinners BL. Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev 2000;19: 167-72.
7. Murray JC, ed. Angiogenesis protocols. Totowa, NJ: Humana Press, 2001:267pp.
8. Auerbach R. Vascular endothelial cell differentiation: organ-specificity and selective affinities as the basis for developing anticancer strategies. Int J Radiat Biol 1991;60:1-10.
9. Gumkowski F, Kaminski G, Kaminski M, Morisset LM, Auerbach R. Heterogeneity of mouse vascular endothelium: In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells. Blood Vessels 1987;24:11-23.
10. Auerbach R, Auerbach W. Assays to study angiogenesis. In: Voest EE, D'Amore PA, eds. Tumor angiogenesis and microcirculation. New York: Marcel Dekker, 2001:91-102.
11. Zetter BR. The cellular basis of site-specific tumor metastasis. New England J Med 1990;322:603-12.
12. Arap RD, Hagbedorn M, Koivunen E, Pasquaiini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 1998;102:430-7.
13. Kolonin M, Pasqualini R, Arap W. Molecular addresses in blood vessels as targets for therapy. Curr Opin Chem Biol 2001;5: 308-13.
14. Schor AM, Ellis I, Schor SL. Chemotaxis and chemokinesis in 3D macromolecular matrices. In: Murray JC, ed. Angiogenesis protocols. Totowa, NJ: Humana Press, 2001:163-204.
15. Obeso JL, Auerbach R. A new microtechnique for quantitating cell movement in vitro using polystyrene bead monolayers. J Immunol Methods 1984;70:141-52.
16. Obeso J, Weber J, Auerbach R. A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab Invest 1990;63:259-69.
17. Auerbach R, Bielich H, Obeso J, Weber J. Quantitation of endothelial cell movement: an in vitro approach to vasculogenesis and angiogenesis. Issues Biomed 1991;14:180-9.
18. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988;106:1375-84.
19. Grant DS, Kibbey MC, Kinsella JL, Cid MC, Kleinman HK. The role of basement membrane in angiogenesis and tumor growth. Pathol Res Pract 1994;190:854-63.
20. Grant DS, Kleinman HK, Leblond CP, Inoue S, Chung AE, Martin GR. The basement-membrane-like matrix of the mouse EHS tumor: II. Immunohistochemical quantitation of six of its components. Am J Anat 1985;174:387-98.
21. Grant DS, Kinsella JL, Fridman R, Auerbach R, Piasecki BA, Yamada Y, et al. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 1992;153:614-25.
22. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 1990;63:115-22.
23. Burbridge MF, West DC. Rat aortic ring: 3D model of angiogenesis in vitro. In: Murray JC, ed. Angiogenesis protocols. Totowa, NJ: Humana Press, 2001:85-204.
24. Plendl J, Hartwell L, Auerbach R. Organ-specific change in Dolichos biflorus lectin binding by myocardial endothelial cells during in vitro cultivation. In Vitro Cell Dev Biol 1993;29A:25-31.
25. Plendl J, Gilligan BJ, Wang S-J, Lewis R, Shinners B, Vandenbroeck K, et al. Primitive endothelial cell lines from the porcine embryonic yolk sac. In Vitro Cell Dev Biol Animal 2002;in press.
26. Muthukkaruppan VR, Shinners BL, Lewis R, Park S-J, Baechler BJ, Auerbach R. The chick embryo aortic arch assay: a new, rapid, quantifiable in vitro method for testing the efficacy of angiogenic and anti-angiogenic factors in a three-dimensional, serum-free organ culture system. Proc Am Assoc Cancer Res 2000;41:65.
27. Algire GH. An adaptation of the transparent chamber technique to the mouse. J Natl Cancer Inst 1943;4:1-11.
28. Fox SB. Microscopic assessment of angiogenesis in tumors. In: Murray JC, ed. Angiogenesis protocols. Totowa, NJ: Humana Press, 2001:29-46.
29. Padhani AR, Neeman M. Challenges for imaging angiogenesis. Br J Radiol 2001;74:886-90.
30. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, et al. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 1991;174:1070-6.
31. 2 and angiogenesis. Proc Soc Exp Biol Med 1983;172:214-8.
32. Brooks PC, Montgomery AM, Cheresh DA. Use of the 10-day-old chick embryo model for studying angiogenesis. Methods Mol Biol 1999;129:257-69.
33. Auerbach R, Kubai L, Knighton D, Folkman J. A simple procedure for the long term cultivation of chicken embryos. Dev Biol 1974; 41:391-4.
34. Auerbach R, Kubai L, Sidky YA. Angiogenesis induction by tumors, embryonic tissues and lymphocytes. Cancer Res 1976;36: 3435-40.
35. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1974;136:261-76.
36. Muthukkaruppan VR, Auerbach R. Angiogenesis in the mouse cornea. Science 1979;205:1416-8.
37. Muthukkaruppan VR, Kubai L, Auerbach R, Tumor-induced neovascularization in the mouse eye. J Natl Cancer Inst 1982;69:699-708.
38. Kisker O, Becker CM, Prox D, Fannon M, D'Amato R, Flynn E, et al. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 2001;61: 7669-74.
39. Akhtar N, Auerbach R. The sponge Matrigel angiogenesis assay. Angiogenesis 2002;5:in press.
40. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 1996;37:1625-32.
41. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab Invest 1982;67: 519-28.
42. Johns A, Freay AD, Fraser W, Korach KS, Rubanyi GM. Disruption of estrogen receptor gene prevents 17β estradiol-induced angiogenesis in transgenic mice. Endocrinology 1996; 137:4511-3.